Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

80.0%

-6.5% vs industry average

Late-Stage Pipeline

83%

5 trials in Phase 3/4

Results Transparency

25%

1 of 4 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 4

5(100.0%)

5Total

Phase 4(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT01706237Phase 4Withdrawn

Visual Outcomes And Contrast Sensitivity After Myopic Wavefront-Optimized Lasik With Nexisvision Shield Or Bandage Contact Lens

Role: lead

NCT00821236Phase 4Completed

Contralateral Comparison of Three Excimer Laser Systems in Performing LASIK

Role: lead

NCT01693939Phase 4Completed

Evaluation of the Post-LASIK Flap Thickness of the FS200 Femtosecond Laser Flap

Role: lead

NCT00781092Phase 4Completed

A Prospective, Randomized, Double-Masked, Single Center, Clinical Comparison of the Use of Systane Ultra in the Management of Dry Eyes in Bilateral Eyes

Role: lead

NCT01193231Completed

A 6 Month Study to Evaluate the Safety, Analgesic Efficacy of ACUVAIL™ (Ketorolac Tromethamine Ophthalmic Solution) 0.45%, in Post-PRK Corneal Wound Healing

Role: lead

NCT00770094Phase 4Unknown

Multi Laser Platform Comparison Study for LASIK

Role: lead

All 6 trials loaded